文献检索/Expert Opinion on Drug SafetyEM-T3Expert Opinion on Drug Safety2022-06-24第 21 卷第 12 期，1495-1503开放获取Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trialYoichiro HashimotoKumamoto City HospitalMika KomoriEli Lilly (Japan)Yuka TanjiEli Lilly (Japan)Akichika OzekiEli Lilly (Japan)Koichi HirataDokkyo Medical University开放获取全文去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词lasmiditanacute migraine treatmentcardiovascular risk factorscardiovascular contraindicationsmigraine with auratreatment-emergent adverse eventsJapanese patientsdrug safetydrug efficacymigraine disability参考文献25引证文献1相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
